)
Funding Opportunities
The Marathon of Hope Cancer Centres Network is an exciting program managed by the Terry Fox Research Institute with support from the federal government. The MOHCCN’s mission is to bring together leading cancer centres across Canada to collaborate on precision medicine to benefit cancer patients and drive innovation.
To allocate its resources, the MOHCCN has international experts evaluate the excellence and the potential for impact of all its research projects.
PROGRAMS FOR FUNDING RESEARCH
Training Program - Health Informatics & Data Science Awards
Training Program - Clinician-Scientist Awards
Patient Voices in Research Initiative
This funding opportunity aims to support research studies that centre patients, caregivers, and survivors and their needs as it relates to precision cancer research and care. It is driven by research themes identified by the Patient Working Group and has a goal of amplifying patient voices and priorities to elevate the quality and impact of cancer research in Canada.
Special Initiatives
The MOHCCN funds special initiatives to ensure representativity and equity from coast to coast in our Network. By investing in precision medicine initiatives in areas that are generally underserved, such as rural, remote and Northern regions, we are working to bring life changing research to more Canadians. As the Network continues to grow, we are also funding projects that pilot new techniques and technologies that allow us to look at scientific questions from new perspectives.
FUNDING OPPORTUNITIES CURRENTLY OPEN IN THIS PROGRAM:
- TFRI-MOHCCN Technology Development Award
MOHCCN Gold Cohort - Regional Consortium Projects
MOHCCN Gold Cohort - Pan-Canadian Projects
The MOHCCN Pan-Canadian Projects program unites researchers and clinicians from multiple provinces to work on projects that cut across regions to accelerate precision medicine for cancer in Canada. In total, the Network will fund 20 groups through this initiative, representing a multi-million-dollar investment over the next three years that will contribute roughly 6,000 cases to the MOHCCN Gold Cohort, the largest and most complete cancer case resource in Canada.
-
Regional Consortia
Atlantic Cancer Consortium
We have rallied our region’s leading cancer researchers, institutions and care facilities to unite around this vision to enhance inter-institutional and inter-provincial cancer research collaboration,...Read more
-
-
Regional Consortia
BC Cancer Consortium
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more
-
-
Regional Consortia
Marathon of Hope - Québec
The Marathon of Hope – Québec (MOH-Q) brings together leading scientists and clinicians from hospitals and research centres including the Research Institute of the McGill University Health Centre (RI-...Read more
-
-
Regional Consortia
Pan-Canadian Projects
Building on work done by Regional Consortia across the country, the Pan-Canadian Projects program unites researchers and clinicians from multiple provinces to work on projects that accelerate precisio...Read more
-
Regional Consortia
Prairie Cancer Consortium
The overall vision of the PR2C is to create a collaborative, inclusive, equitable, and sustainable multiprovincial initiative that works towards developing new treatment strategies for patients facing...Read more
-
-
Regional Consortia
Princess Margaret Cancer Consortium
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...Read more
-
News
-
PM2 CAN-IMPACT-IO a national immunotherapy biospecimen collection study has now opened
PM2 CAN-IMPACT-IO is a unique national initiative to measure, predict and assess cancer treatment outcomes in patients who have been treated with immunotherapy. Patients on CCTG clinical trials who co... -
Eight pan-Canadian research teams receive newly created TFRI-MOHCCN Technology Development Awards
New joint funding initiative from TFRI and the MOHCCN will support the deployment of novel technologies to accelerate precision medicine for cancer Eight outstanding research teams from across the country will receive a total of $2.2M from the Terry Fox Research Institute (TFRI) and the Marathon of Hope Cancer Centres Network (MOHCCN) to develop,... -
Meet the Team Canada of Cancer Research: A Q&A with Dr. Catalina Lopez-Correa
A Q&A with Dr. Catalina Lopez-Correa, a genomics scientist, a trained physician, an administrator, and now a cancer patient, who has been championing the use of genomics as a transformative tool i... -
Atlantic Cancer Consortium leadership and members share updates with the Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing... -
New study highlights long-read sequencing applications in precision oncology
A team of researchers that includes Marathon of Hope Cancer Centres Network members demonstrate applications for long-read sequencing in precision oncology in a new study published in Cell Genomics. -
Prairie Cancer Consortium leadership and members share updates with the Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing...
